Read The Latest Posts From Our Newsletter.
Our newsletter tracks recent developments in the biotech industry. We explore genetic medicine, AI in biotech and the examine the breakthrough science that is driving our new, advanced medicines.
Kevin Curran, the Bridgepoint Bio founder, is the author of our newsletter. Visit this link to sign up for Kevin’s substack newsletter.
1909, 2024
Do we have a plan for affordable genetic medicine?
The short answer is 'no', but we could build out this path in the next decade.
509, 2024
Commercial issues with gene editing
The science has turned a corner but the financial side remains murky and difficult.
107, 2024
Germline gene editing…might we be accidentally modifying the human lineage?
Designing a gene editing clinical trial requires a thoughtful approach towards the accidental editing of sperm and egg cells.
1706, 2024
How can VLPs help us advance gene editing medicine?
Let's talk about Virus Like Particles... Here, I present part 3 from my video series on gene editing delivery.